📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Molecular Neuroimaging

1.1 - Company Overview

Molecular Neuroimaging Logo

Molecular Neuroimaging

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of neuroimaging services as a biotechnology firm.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Molecular Neuroimaging

Aster Insights Logo

Aster Insights

HQ: United States Website
  • Description: Provider of oncology bioinformatics solutions delivering clinical and molecular data and analytics tools for precision oncology research. Products include Aster Avatar (multimodal dataset with longitudinal clinical and genomic analyses), Aster Galaxy (standardized data library), Aster Navigator (analytics with insights from AI models), Aster Constellation (precision oncology registries and clinical trial matching), and Total Cancer Care®.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Aster Insights company profile →
Jennewein Biotech Logo

Jennewein Biotech

HQ: Germany Website
  • Description: Provider of industrial biotechnology solutions specializing in developing processes for the identification, characterization, and production of scarce, functional monosaccharides and oligosaccharides, with a focus on sugar molecules offering attractive health benefits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jennewein Biotech company profile →
Envigo Logo

Envigo

HQ: United Kingdom Website
  • Description: Provider of essential products and research services to pharmaceutical, crop protection, and chemical companies, as well as universities, governments, and other research organizations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Envigo company profile →
ThreeWire Logo

ThreeWire

HQ: United States Website
  • Description: Provider of customized clinical trial recruitment, enrollment and retention solutions for the pharmaceutical, biotech and medical device industries, addressing enrollment targets and study delays, and offering direct-to-patient marketing services for medical device companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ThreeWire company profile →
Nexelis Logo

Nexelis

HQ: United States Website
  • Description: Provider of assay development and advanced laboratory testing; a portfolio company of Ampersand Capital Partners.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nexelis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Molecular Neuroimaging

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Molecular Neuroimaging

2.2 - Growth funds investing in similar companies to Molecular Neuroimaging

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Molecular Neuroimaging

4.2 - Public trading comparable groups for Molecular Neuroimaging

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Molecular Neuroimaging

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Molecular Neuroimaging

What does Molecular Neuroimaging do?

Molecular Neuroimaging is a provider of neuroimaging services as a biotechnology firm.

Who are Molecular Neuroimaging's competitors?

Molecular Neuroimaging's competitors and similar companies include Aster Insights, Jennewein Biotech, Envigo, ThreeWire, and Nexelis.

Where is Molecular Neuroimaging headquartered?

Molecular Neuroimaging is headquartered in United States.

How many employees does Molecular Neuroimaging have?

Molecular Neuroimaging has 1,000 employees 🔒.

When was Molecular Neuroimaging founded?

Molecular Neuroimaging was founded in 2010 🔒.

What sector and industry vertical is Molecular Neuroimaging in?

Molecular Neuroimaging is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Molecular Neuroimaging

Who are the top strategic acquirers in Molecular Neuroimaging's sector and industry

Top strategic M&A buyers and acquirers in Molecular Neuroimaging's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Molecular Neuroimaging?

Top strategic M&A buyers groups and sectors for Molecular Neuroimaging include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Molecular Neuroimaging's sector and industry vertical

Which are the top PE firms investing in Molecular Neuroimaging's sector and industry vertical?

Top PE firms investing in Molecular Neuroimaging's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Molecular Neuroimaging's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Molecular Neuroimaging's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Molecular Neuroimaging's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Molecular Neuroimaging include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Molecular Neuroimaging's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Molecular Neuroimaging?

The key public trading comparables and valuation benchmarks for Molecular Neuroimaging include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Molecular Neuroimaging for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Molecular Neuroimaging with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Molecular Neuroimaging's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Molecular Neuroimaging with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Molecular Neuroimaging's' sector and industry vertical?

Access recent funding rounds and capital raises in Molecular Neuroimaging's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Molecular Neuroimaging

Launch login modal Launch register modal